secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vor Biopharma Inc. (VOR)
CIK:        0001817229
Form:       8-K
Filed at:   2022-06-17T23:59:59+00:00
Accession:  0001193125-22-176471
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Vor Biopharma stockholders elect three Class I directors and ratify E&Y as auditor
--------------------------------------------------------------------------------

- Stockholders elected Matthew Patterson, Daniella Beckman, and Kush Parmar as Class I directors for terms until 2025.
- Ratification of Ernst & Young LLP as independent auditor for FY2022: 28,763,851 votes for, 3,220 against, 2,428 abstain.
- Approximately 76.69% of eligible shares were represented at the Annual Meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1817229/000119312522176471/0001193125-22-176471-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1817229/000119312522176471/d220959d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-176471

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer